HeartSciences Capital Expenditures (CapEx) Growth & History (HSCS)

HeartSciences's capital expenditures (capex) was $3,554 for fiscal 2026.

View full HeartSciences company overview

HeartSciences annual capital expenditures (capex) history

HeartSciences annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20262026-04-30$3,554$397+12.58%
20252025-04-30$3,157−$61,298−95.10%
20242024-04-30$64,455$46,147+252.06%
20232023-04-30$18,308$16,376+847.62%
20222022-04-30$1,932

HeartSciences capital expenditures (capex) trends

Between the periods ended 2022-04-30 and 2026-04-30, HeartSciences's capital expenditures (capex) increased from $1,932 to $3,554, a change of $1,622. The latest reported quarter, Q4 2026, shows $9,476.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review HeartSciences source filings ↗

Community posts

It’s quiet here.

No posts about HSCS yet. Start the conversation.

Write the first post